FDA Inspection 1224192 — Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd.

Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd. — FEI 3015541467

The FDA completed an inspection of Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd. on Sep 22, 2023 in Zibo. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Sep 22, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Zibo (China)

Additional details

Mutual Recognition Agreement (MRA)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.